Explore our ready-to-market, clinically tested acne serums, topical solutions, and synergistic internal skin-clarifying nutricosmetics designed for international brand deployment.
The global acne treatment market is experiencing a profound paradigm shift. Valued at approximately USD 10.2 Billion in 2024, the market is projected to reach USD 15.8 Billion by 2030, growing at a CAGR of 6.5%. This growth is driven not merely by adolescent demographic demands, but increasingly by adult acne prevalence, environmental stress factors, and the rising consumer awareness of the cutaneous microbiome.
For global brand owners, clinical procurement officers, and private label distributors, sourcing from qualified OEM/ODM acne treatment serum factories and exporters requires far more than basic contract filling. Modern consumers demand clinical efficacy without cutaneous irritation—rejecting harsh, drying chemical treatments in favor of multi-targeted, biomimetic serum formulations that balance the skin barrier while suppressing pathogen proliferation.
To maintain competitive advantage in saturated e-commerce and retail channels, brands must align their product roadmaps with next-generation manufacturing technology. Our international formulation laboratories have identified five core procurement trends shaping the next decade of anti-acne cosmeceuticals:
Sub-micron liposomal encapsulation of Salicylic Acid enables sustained 8-hour follicular delivery, drastically reducing epidermal stinging and erythema while increasing lipid solubility within clogged pores.
Replacement of broad-spectrum antibacterial agents with targeted postbiotics (such as Lactobacillus Ferment Lysate) that selectively downregulate virulent C. acnes phylotypes while keeping protective skin flora intact.
Bundling topical OEM serums with internal nutricosmetic supplements (e.g., Zinc, Apple Cider Vinegar, and Green Tea extract gummies) to treat systemically driven inflammation alongside surface blemishes.
Incorporation of botanical extracellular vesicles and Polydeoxyribonucleotide (PDRN) to accelerate tissue remodeling, repair compromised stratum corneum barrier functions, and eradicate persistent acne scarring.
Global buyers increasingly require JAKIM Halal Certification, EU CPNP registration compatibility, ISO 22716 compliance, and zero animal testing across all raw material supply chains.
Precision dosage airless pump systems made from recycled PCR plastics or refillable glass vessels that preserve unstable active molecules (e.g., L-Ascorbic Acid, Retinoids) without heavy chemical preservatives.
Our state-of-the-art R&D laboratories engineer custom OEM/ODM acne serums tailored to specific market positioning—from rapid spot emergency treatments to gentle daily barrier-repair drops. Below is an engineering overview of our primary active ingredient matrices available for custom manufacturing:
| Active Chemical Agent | Primary Target Mechanism | Key Clinical Benefit | Recommended OEM Concentration |
|---|---|---|---|
| Encapsulated Salicylic Acid (BHA) | Lipophilic pore desquamation | Dissolves squalene oxidation, clears comedones | 0.5% – 2.0% |
| Niacinamide (Vitamin B3) + Zinc PCA | 5-alpha reductase inhibition & IL-6 reduction | Regulates sebum flow, reduces erythema & PIH | 4.0% – 10.0% Niacinamide / 1.0% Zinc |
| Azelaic Acid Derivative (PAD) | Tyrosinase & follicular keratinization control | Fades post-acne marks, non-irritating brightening | 3.0% – 8.0% |
| Centella Asiatica (CICA) + Madecassoside | Fibroblast stimulation & barrier repair | Soothes inflamed papules, prevents scar formation | 1.0% – 5.0% |
| Lactobacillus Ferment (Postbiotics) | Microbial competitive inhibition | Rebalances microbiome, reinforces skin immunity | 2.0% – 5.0% |
By mastering chemical solubility, pH stabilizing buffers (maintaining optimal skin acidic mantle at pH 4.5–5.5), and viscosity control agents, our manufacturing plant ensures zero phase separation, crystal precipitation, or discoloration throughout the product's 36-month shelf life.
As Malaysia’s most complete one-stop OEM/ODM manufacturing conglomerate, ORIZI Group operates six specialized subsidiaries across three core industrial divisions: Cosmetics & Skincare, Functional Food & Supplements, and Medical Devices. With over two decades of international supply chain expertise, we empower global brands to scale seamlessly from boutique launches to multi-million unit retail rollouts.
Our facilities hold JAKIM Halal Certification, ISO 22716 (GMP Cosmeceuticals), ISO 13485 (Medical Devices), HACCP, and MDA Licenses. Audited by SEDEX / SMETA for social and ethical workplace compliance.
We manage every phase of development: raw material sourcing, proprietary R&D custom formulation, stability and challenge testing, silk-screen bottle printing, secondary box packaging, and export customs clearance.
Equipped with pharmaceutical-grade vacuum emulsifying mixers, high-speed multi-head airless serum filling machines, and automated labeling equipment capable of producing over 60,000 units daily.
Define target audience, active ingredient preferences, texture, and pricing goals. Our R&D chemists blend custom prototype samples within 24–48 hours for client evaluation.
Finalize container vessel selections (droppers, airless pumps), artwork die-lines, ingredient declarations, barcode assignment, and export compliance dossier preparation.
High-shear vacuum emulsification in ISO 22716 cleanrooms, inline micro-filtration, automated volume dosing, induction sealing, and strict quality control sampling.
Final microbiological and heavy metal testing release. Goods are palleted, stretch-wrapped, and loaded for global container sea freight or express air cargo export.
Partner with Southeast Asia’s premier certified OEM/ODM acne serum factory. Request our complete 2026 Product Catalog, raw material specifications, and sample trial kit today.
